CEimpact Podcast

Updated osteoporosis guidelines have arrived from the American Association of Clinical Endocrinology. The AACE guidelines include different recommendations from the 2017 National Osteoporosis Foundation guidelines, primarily due to new anabolic agents. Learn about a newly created a new patient risk stratified category, the role of bisphosphonates, and how to approach patient care. Additional Resou...

Medications are only 10 percent of total US healthcare expenditure, yet remain a focus of healthcare costs. In this Gamechangers episode, Geoff Wall and guest, Jake Galdo, will discuss two articles evaluating generic utilization on Medicare costs. By giving up brands, can we lower costs? Additional Resource/Reference: https://jamanetwork.com/journals/jamacardiology/article-abstract/2770174 and htt...

Antibiotics are a risk factor for Clostridium difficile infections. Combining a review of the 2017 Infectious Diseases Society of America and recent literature for prophylactic therapies, learn how to care for patients between a rock and a hard place. Additional Resource/Reference: https://learn.ceimpact.com/library/group/12/course/2313 This episode is accredited for CPE. Subscribe at CEimpact (ht...

The TAILOR-PCI Trial evaluates the outcomes between genotype-guided P2Y12 inhibitor selection versus conventional prescribing on ischemic outcomes. Listen to Geoff Wall and guest, Jake Galdo, discuss the role of pharmacogenomics in patient care. Additional Resource/Reference:https://jamanetwork.com/journals/jama/article-abstract/2769725 This episode is accredited for CPE. Subscribe at CEimpact (ht...

New guidelines from American College of Physicians suggest that first-line treatment of non-low back musculoskeletal injuries are topical therapies. Topical non-steroidal anti-inflammatory drugs, like diclofenac, are available as over-the-counter products in the US. Learn about the preferred route of care when treating pain. Additional Resource/Reference: https://www.acpjournals.org/doi/10.7326/M1...

Community Pharmacies are vital members of neighborhoods and the healthcare community. A major social determinant of health is access to healthcare - both providers and medications. Recently, Berenbrok and colleagues published research that showed community pharmacies are visited almost twice as much compared to primary care providers by Medicare beneficiaries annually. Guest Jake Galdo will be joi...

The COVID-19 pandemic continues to rage on worldwide. Data surrounding the treatment of patients with COVID-19 respiratory failure is moving at lightning pace, so for this week's episode we will discuss the latest (as of 8/13/20) information surrounding two modalities for COVID-19 treatment: convalescent plasma and tocilizumab. This episode is accredited for CPE. Subscribe at CEimpact (https:...

A recent retrospective database study found that in patients on new oral anticoagulants prescribed clarithromycin, compared to azithromycin, were assocated with an increased risk of major beeding. We will discuss this paper and other common drug interactions the practicing pharmacists should be vigilant about. This episode is accredited for CPE. For CE details and to claim credit, click here: http...

A recent study suggests that SGLT2 drugs - now shown to dramatically improve cardiovascular and renal outcomes in a wide variety of patients - have a higher incidence of euglycemic DKA than previously thought.  If pharmacists see more of this ADR, how do we treat appropriately - especially when a patient's sugars may not be very high? This episode is accredited for CPE. For CE details and to...

Most prescribers believe that short course of steroids have no serious adverse effects, but a recent study from the Annals of Internal Medicine challenges that notion.  What does the pharmacist need to know about the short and long term adverse effects of steroids and how to proactively prevent them? Additional Resources/ReferencesAssociation between Oral Corticosteroid Bursts and Severe Adverse E...

Ethanol use disorder continues to be a major problem in the U.S.  The stress and anxiety related to the COVID-19 pandemic may exacerbate alcohol use disorder. Tune in to this episode to learn the latest in guideline updates relative to the management of ethanol withdrawal. Additional Resources/ReferencesAlcohol Withdrawal Management Guideline: https://www.asam.org/Quality-Science/quality/guideline...

Geoff Wall, PharmD delivers another great podcast. Pharmacists see skeletal muscle relaxant prescriptions daily but how much real experience  do we  have with these drugs?  Do they work?  Are they safe?  This episode covers what should every pharmacist know about these medications. This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2CEy161 See omnyst...

Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients.  A recent study conducted in the United Kingdom suggests that the steroid dexamethasone may be a weapon for prevention.  In this episode, we discuss the study that caused the National Health Service in the U.K. and the CDC to change their recommendations for steroids and sever...

The COVID-19 pandemic has disproportionally affected Latinx Americans.  Learn how pharmacists can optimize patient care for Latinx patients by discussing how to overcome economic and language barriers.  In this episode, we'll talk with Dr. Sally Haack who cares for Latinx patients on a daily basis in her pharmacy practice. Special guest: Sally Haack, PharmD, BCPS Associate Professor Drake Uni...

Many patients over age 65 take daily medications that have anticholinergic properties. We know the addition of these drugs can affect quality of life and cognition.  In this episode, we talk with Dr. Kristin Meyer, an expert in geriatrics to  explore the latest data and discuss what Pharmacists can do to promote the appropriate use of anticholinergics. Additional Resources/ReferencesBeers Criteria...

The American College of Rheumatology recently published new guidelines for the treatment of Gout. While gout is well understood and the medications to treat gout are both effective and affordable, implementation of the new ARC guidelines will, ideally, lead to improved quality of care for patients with gout.  In this episode, Dr. Wall discusses guideline changes and important pearls so pharmacists...

Racism is a public health emergency and a root cause of social determinants of health. If we are to practice patient-centered care, and education our pharmacists to better serve their patients, we ought to act to dismantle structural racism and start by having some honest conversations. In this episode, we'll talk with Dr. Vibhuti Arya about our role as pharmacists in addressing this public h...

Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know that vitamin D is a safe fat soluable vitamin that is difficult to "overdose" on.  What should the pharmacist know in terms of repletion dose and signs of toxicity? Since many patients do not get enough vitamin D in their diets, large medical societies an...

Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID,  is the subject of this episode. This episode is accredited for CPE.  For CE details and to claim credit click here:  https://bit.ly/3hn191p See omnystudio.com/listener for privacy information...

Buprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet < 10% patients with Opioid Use Disorder receive drug treatment. In this episode, we discuss what the general pharmacist needs to know about the most powerful weapon we have for Opioid Use Disorder: buprenorphineThis episode is accredited for CPE.  This episode is accredited for CPE.  For CE det...

Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar.  Recently SGLTs, which are currently indicated for Type 2 diabetes, have been investigated and received FDA approval for Heart failure with reduced ejection fraction (HFrEF).  Listen in to...

GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection.  In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection.  Emerging evidence suggests that patients with COVID infection may be hypercoagulable and prone to clotting. Listen in as we discuss the evidence surrounding this issue an...